What is the recommended hormone work-up and treatment plan for Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone Work-Up for PCOS

The essential hormone work-up for PCOS includes TSH, prolactin, and total testosterone (or free/bioavailable testosterone), followed by a 2-hour oral glucose tolerance test with 75-gram glucose load and fasting lipid panel to assess metabolic complications. 1

Core Hormonal Testing to Establish Diagnosis

Androgen Assessment:

  • Total testosterone or bioavailable/free testosterone is the single most important hormonal marker, with abnormal values in 70% of PCOS patients 2
  • Androstenedione should be measured as it is elevated in 53% of PCOS cases 2
  • DHEA-S (dehydroepiandrosterone sulfate) helps exclude adrenal androgen-secreting tumors 1
  • The combination of testosterone, androstenedione, or LH identifies 86% of PCOS patients 2

Exclude Other Endocrine Disorders:

  • TSH level to rule out thyroid disease 1
  • Prolactin level to exclude hyperprolactinemia 1
  • These tests are mandatory before confirming PCOS diagnosis 1

Gonadotropin Testing (Optional):

  • LH and FSH measurements are less useful than previously thought 2
  • LH/FSH ratio should NOT be used as a diagnostic criterion due to low sensitivity (abnormal in only 41-44% of cases) 2
  • Mean LH is elevated in PCOS but only abnormal in 35% of patients 2

Metabolic Screening (Mandatory for All PCOS Patients)

Glucose Metabolism:

  • Fasting glucose followed by 2-hour glucose level after 75-gram oral glucose load is required for all PCOS patients due to increased diabetes risk 1
  • This recommendation is based on ACOG consensus that PCOS patients have demonstrated increased risk for type 2 diabetes 1

Lipid Assessment:

  • Fasting lipid panel including total cholesterol, LDL, HDL, and triglycerides is mandatory 1
  • PCOS patients frequently have dyslipidemia with elevated LDL, elevated triglycerides, and decreased HDL 1
  • This screening is based on good and consistent scientific evidence per ACOG 1

Anthropometric Measurements:

  • Calculate BMI and waist-hip ratio at initial evaluation 1

Additional Testing for Specific Clinical Scenarios

Signs of Cushing's Syndrome:

  • Screen for Cushing's if patient has buffalo hump, moon facies, hypertension, abdominal striae, centripetal fat distribution, easy bruising, or proximal myopathies 1

Marked Virilization or Rapid Symptom Onset:

  • Requires immediate evaluation for androgen-secreting tumors of ovary or adrenal gland 3
  • Measure total testosterone and DHEA-S urgently 1

Prepubertal Children:

  • Evaluate for early-onset body odor, axillary/pubic hair, accelerated growth, advanced bone age, and genital maturation 1
  • Use growth charts and hand film for bone age as screening tools before specific hormonal testing 1

Postpubertal Females with Hyperandrogenism Features:

  • Test when infrequent menses, hirsutism, androgenetic alopecia, infertility, clitoromegaly, or truncal obesity are present 1
  • Typical hormone panel includes free and total testosterone, DHEA-S, androstenedione, LH, and FSH 1

Critical Pitfalls to Avoid

  • Do not rely on LH/FSH ratio alone - it has poor sensitivity and should be abandoned as a diagnostic criterion 2
  • Do not measure hormones while patient is on oral contraceptives - OCPs suppress FSH, LH, and estradiol by design, making interpretation impossible 4
  • Do not use SHBG combined with testosterone to derive free testosterone - this does not improve diagnostic accuracy over total testosterone alone 2
  • Ensure normal ranges are defined for your specific laboratory assay - absolute gonadotropin values differ significantly between assay methods 2
  • Measure hormones in early follicular phase (if patient has cycles) for accurate interpretation 2

Treatment Considerations Based on Work-Up Results

For Non-Pregnant Patients:

  • Combination oral contraceptive pills are first-line for menstrual regulation and androgen suppression 1
  • Metformin is first-line for metabolic manifestations including hyperglycemia 3
  • Weight loss and lifestyle modification should precede drug therapy for dyslipidemia 1

For Fertility Concerns:

  • Insulin-sensitizing agents (metformin) improve ovulation frequency based on good and consistent scientific evidence 1
  • Clomiphene and letrozole are first-line medications for infertility 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Research

Diagnosis and Treatment of Polycystic Ovary Syndrome.

American family physician, 2016

Guideline

Management of PCOS Patients with Suppressed Gonadotropins on OCPs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.